CREATE MEDICINES
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99365272
- Mark type
- Stylized text
- Filed
- 29 Aug 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Biological and medicinal preparations and substances for the prevention and treatment of oncological and immune system related diseases and disorders, and for use with transplantation; biological and medicinal preparations and substances for the prevention and treatment of fibrosis; biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine; biological and medicinal preparations and substances for the prevention and treatment of cancer and infectious diseases; anti-cancer preparations; biological and medicinal preparations and substances for treating genetic diseases
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the fields of cancer, oncology, autoimmune and infectious diseases, and transplantation; medical and scientific research services in the fields of the prevention and treatment of cancer, oncology, autoimmune and infectious diseases, and transplantation; medical and scientific research services in the fields of the prevention and treatment of fibrosis; medical and scientific research services in the field of regenerative medicine; research and development of regenerative medicine; medical and scientific research services in the field of genetic diseases and disorders; providing laboratory research services in the fields of cancer biology, cancer, oncology, autoimmune and infectious diseases, and transplantation
- Class 044 — Medical, beauty and agricultural services: Medical services for the prevention and treatment of cancer and autoimmune and infectious diseases; medical services for the prevention and treatment of fibrosis; medical services in the field of regenerative medicine; medical services for the prevention and treatment of genetic diseases; providing information in the field of cancer, autoimmune and infectious diseases, fibrosis, and genetic diseases and disorders
Owner
- CREATE MEDICINES, INC., CAMBRIDGE, MA, US
- Myeloid Therapeutics, Inc., Cambridge, MA, US
- Myeloid Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 11 Feb 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 17 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 17 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 13 Jan 2026 — ASSIGNED TO EXAMINER
- 29 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 29 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Aug 2025 — NEW APPLICATION ENTERED